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ABSTRACT 
Objective: Fortunella japonica (Thunb.) Swingle is an evergreen shrub, its whole fruit, including the peel, is eaten. There have been few detailed 
phytophenolics composition reports on this genus and the hypoglycemic and hypolipidemic effects of the plant were not evaluated.  
Methods: Structures of the isolated compounds were elucidated by spectral analysis. Serum glucose level, activities of liver enzymes, total protein 
content, serum lipid profiles, antioxidant parameters and some glycolytic and gluconeogenic enzymes in streptozotocin (STZ)-induced diabetic rats 
were determined. The evaluation also carried out through determination of liver disorder biomarkers and histopathological examination of liver, 
kidney and pancreas.  
Results: Six phytophenolics were isolated, for the first time from the genus Fortunella as well as a sterol compound. Treatment with the ethanolic 
extract of F. japonica leaves effectively meliorated antioxidant markers and glycolytic enzymes. The histopathological analyzes also confirmed the 
experimental findings.  
Conclusion: The results show that the ethanolic extract has hypoglycemic, hypotriglyceridemic and antioxidant effects in STZ-induced diabetic rats, 
suggesting that this extract supplementation can be useful in preventing diabetic complications associated with hyperlipidemia and oxidative stress. 
Keywords: Fortunella japonica, Phytophenolics, Hyperglycemia, Hyperlipidemia, Oxidative stress, Streptozotocin. 
 
INTRODUCTION 
Fortunella japonica (Thunb.) Swingle belongs to family Rutaceae. 
The plant bears small, bright orange oblong fruits that have an 
edible, sweet rind and a sour, acidic pulp [1]. It is used as 
antiphlogistic, antitussive, carminative, deodorant and expectorant 
in folkloric medicine.  
There have been few detailed phytochemical reports on Fortunella 
genus. Isolation of a bioactive stimulator of uterine contraction; 
kaurene diterpene and coumarins; sesselin, xanthyletin and 
suberosin, from the roots of F. margarita [2] and a dihydrochalcone 
derivative was detected in the fruits [1]. Talapatra et al. [3] isolated 
nobiletin, tangeretin and 5, 7, 8, 3′, 4′-pentamethoxy flavones in the 
fruits of F. japonica. While the reverse-phase liquid chromatography 
hyphenated with photodiode-array detection and tandem 
electrospray ionization mass spectrometry (LC-DAD-ESI-MS) 
analysis of its crude juice resulted in the detection of acacetin 3,6-di-
C-glucoside, lucenin-2 4′-methyl ether, narirutin 4′-O-glucoside, 
vicenin-2, and apigenin 8-C-neohesperidoside [4]. 
The majority of research programs is directed towards the 
investigation of Fortunella fruits and peels volatile [5, 6] constitutive 
due to their antimicrobial, acetylcholinesterase inhibitor, anti-
inflammatory, and antiproliferative effect [7, 8]. 
Chemoprevention by dietary means continues to attract major 
attention for the management of degenerative diseases primarily 
due to the dramatic rise of hyperlipidemia and hyperglycemia as 
major metabolic disorder healthcare problem affecting a huge 
population all over the world [9]. Hyperlipidemia is one of the major 
health problems because of the close correlation between 
cardiovascular diseases and lipid abnormalities [10].  
Hyperglycemia results from abnormalities in insulin secretion 
and/or insulin action, both caused by impaired metabolism of 
glucose, lipids and proteins [11]. In hyperglycaemics, impaired 
carbohydrates accelerate lipolysis, resulting in hyperlipidemia [9]. 
Despite the presence of known antihyperglycemic pharmaceuticals, 
hyperglycemia and the related complications continue to be a major 
medical problem. Natural products have been long considered 
promising antidiabetic agents because of their potent effects and low 
toxicities. Searching for new safe antihyperglycemic 
phytopharmaceuticals is still attractive [9, 12-14]. 
Plant extracts and their constituents as a natural source of 
antioxidative have been extensively reviewed [15, 16]. Plant extracts 
containing low molecular mass compounds have been successively 
used in phytotherapy since ancient times, as reactive oxygen species 
(ROS) are involved in several diseases, research on the antioxidant 
potential of medicinal plants. 
In the light of this, the present study was initiated to find out the 
phytophenolics composition of the leaves of F. japonica and the bio-
potential of the ethanolic extract as antihyperlipidemic, 
antihyperglycemic, and antioxidant oxidative stress. 
MATERIALS AND METHODS 
Plant material 
Fortunella japonica (Thunb.) Swingle leaves were collected and 
kindly identified by Ali Al-Jaleel, Najran Horticulture Research and 
Development Centre, Ministry of Agriculture, Food and Agriculture 
Organization, Najran, Kingdom of Saudi Arabia in December 2013. 
Chemicals and analytical instruments 
The high analytical grade chemicals from Sigma (USA), Merck 
(Germany), BDH (England), Riedel de Hàen (Germany) and Fluka 
(Switzerland) were used. The kits used were be Biosystems (Spain), 
Sigma (USA) and Biodiagnostic (Egypt). The NMR spectra were 
recorded at 300 (1H) and 75 (13C) MHz, on a Varian Mercury 300 
NMR spectrometer in the convenient solvent. The δ values are 
reported in ppm relative to TMS and J values in Hz. A Laborota 4010 
rotary evaporator (Heidolph Instruments, Schwabach, Germany) 
was used and UV analyses for pure samples were recorded, 
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separately, in methanol solutions and with different diagnostic UV 
shift reagents on a Shimadzu UV 240 (P/N 240–58000). Electron 
spray ionization mass spectrometry (ESI-MS) measurements were 
run on a double focusing Mat 95 sector field mass spectrometer 
(Finnigan, Bremen, Germany).  
Phytophenolics investigation 
Materials used for chromatographic analysis  
For column chromatography, silica gel (Si) 60 mesh 60-120 (E. 
Merck, Darmstadt, Germany), and Sephadex LH-20 (Pharmacia, 
Uppsala, Sweden) were used. Whatman No. 1 paper sheets 
(Whatman Ltd., Maidstone, England) and pre-coated silica gel 60 F254 
plates were used for paper chromatography (PC) and thin layer 
chromatography (TLC), respectively. 
Solvent systems  
S1 [C6H14/EtOAc (7:3, v/v), S2 [C6H6/EtOAc (9.5:0.5, v/v)], S3 
[CHCl3/MeOH, (8:2, v/v)], S4 [n-BuOH/HOAc/H2O, (4:1:5, v/v/v, top 
layer)], and S5 (15% aqueous HOAc) were used. 
Spray reagents 
The pure compounds were visualized by spraying with 
iodine/potassium iodide (I2/KI, I); AlCl3 (1 % ethanol, II), Naturstoff 
(1 % methanolic solution of diphenyl boric acid-ethanolamine 
complex and a 5 % ethanolic solution of polyethylene glycol 400, III), 
ρ-anisaldehyde-sulphuric acid reagent (0.5 ml ρ-anisaldehyde is 
mixed with 10 ml glacial acetic acid, followed by 85 ml methanol and 
5 ml concentrated sulfuric acid, and heat to 105 °C, IV), and aniline 
hydrogen phthalate (0.93 g aniline and 1.66 g phthalic acid dissolved 
in 100 ml n-butanol saturated with water, and heat to 105 °C, V). 
Extraction and isolation of phytophenolics 
Fresh leaves of F. japonica (Thunb.) Swingle (1 kg) were successively 
and exhaustively extracted with petroleum ether (40-60 °C) and EtOAc 
using a soxhlet apparatus. Each extract was distilled in vacuo at 50 °C 
giving a residue of 30.4 and 48.6 g, respectively. An aliquot of the 
petroleum ether-soluble portion (20 g) loaded onto a Si column, which 
was chromatographed using toluene/EtOAc (9:2) to give compounds 1 
(15 mg) and 3 (10 mg). The EtOAc-soluble portion was 
chromatographed over Si using gradient elution with toluene/ethyl 
acetate (100:0-0:100, v/v) and the fractions of the similar 
chromatographic profile were collected to give four main fractions. 
The first fraction was chromatographed on Si using n-hexane/EtOAc 
(9:1) and (9:3) afforded compounds 2 (16 mg) and 4 (11 mg), 
respectively. Compounds 1-4 were purified after crystallization from 
methanol. Screening of second and third fractions was done by 
comparative PC (Co-PC) using Whatman No. 1 sheets, and S4 and S5 as 
solvent systems. Visualization of the chromatograms was achieved by 
UV (365 nm) using III and/or IV spray reagents. These fractions were 
chromatographed on different columns viz., Si column 
chromatography (eluted successively with a step gradient of n-hexane-
CH2Cl2 (100:0-0:100 v/v) then gradual increase polarity with 
methanol) and Sephadex LH-20 (using n-BuOH/iso-propanol/H2O 
(BIW, 4:1:5 v/v/v, top layer), methanol or methanol-water mixture 
(9:1) as different eluents. Accordingly from the previous fraction, 
compounds 5 (15 mg), 6 (13 mg), and 7 (15 mg) were obtained. 
The seven major compounds were isolated, their purity being 
checked by comparative TLC using solvent systems S1-S3 for 
compounds 1-4 and by Co-PC using S4 and S5 for compounds 5-7. 
Spray reagents I for compound 1, II for compounds 2-4 and III and 
IV for compounds 5–7 were used. The chromatographic of 
compounds 5–7 properties (color under UV light, change with 
ammonia vapor and responses towards spray reagents) can suggest 
their flavonoid characters. All compounds were characterized 
mainly by spectroscopic methods; UV, MS, 1H and 13C NMR as well as 
a comparison of the melting points with authentic samples or those 
in the literature. 
Isolated compounds 
The spectral data of the isolated of compounds were illustrated as 
the following:  
Compound (1): White crystals; m. p. 136-137 °C; C29H50O; Rf= 0.53 
(S1); MS m/z (100 %): 414 [M+, 65.0], 415 [M++H, 100], 399 [M+-OH, 
30.0], 397 [M+-OH, 40.4], 330 [49.8], 302 [19.7], 273 [23.6], 255 
[49.8], 231[33.5], 312 [33.5]; 1H NMR (DMSO-d6, 300 MHz): δ ppm 
5.36 (1H, d, J= 5.4 Hz, H-6), 3.54 (1H, m, H-3);13C NMR (75 MHz, 
DMSO-d6): δ ppm 140.8 (C-5), 121.7 (C-6), 71.8 (C-3), 56.8 (C-
14/17), 50.2 (C-9), 45.9 (C-24), 42.3 (C-4/13), 39.8 (C-12), 37.3 (C-
1), 36.5 (C-10), 36.2 (C-20), 34.0 (C-22), 31.9 (C-7/8), 31.7 (C-2), 
28.3 (C-16), 26.2 (C-23), 24.3 (C-15), 29.2 (C-25), 23.1 (C-28), 21.1 
(C-11), 19.8 (C-26), 19.4 (C-19), 19.1 (C-27), 18.8 (C-21), 12.0 (C-29), 
11.9 (C-18). 
Compound (2): White crystals; m. p. 226-228 °C; C9H8O3; Rf = 0.33 
(S2); 0.45 (S3); UV λmax (MeOH): 323 nm; MS m/z (100 %): 162 [M+, 
86.7], 134 [M+-CO, 100], 106 [M+-2CO, 24.7], 78 [C6H6+, 74.7]; 1H 
NMR (300 MHz, CDCl3): δ ppm 7.91 (1H, dd, J ~9.5, 1.2 Hz, H-4); 7.51 
(1H, dd, J= 8.5,1.2 Hz, H-5); 6.75 (1H, m, H-6), 6.70 (1H, s, H-8), 6.19 
(1H, dd, J ~9.5, 1.8 Hz, H-3); 13C NMR (CDCl3, 75 MHz): δ ppm 161.2 
(C-7), 160.4 (C-2), 155.4 (C-9), 144.4 (C-4), 129.6 (C-5), 113.1 (C-6), 
111.3 (C-3), 111.2 (C-10), 102.1 (C-8).  
Compound (3): Yellow crystals; m. p. 150-151 °C; C13H10O5;Rf= 0.52 
(S3); 0.49 (S5); UV λmax (MeOH): 246sh, 267, 310 nm; MS m/z (100 
%): 246 [M+, 88.9], 231 [M+-CH3, 100], 203 [M+-CH3,-CO, 20.7], 188 
[M+-2CH3-CO, 24.2], 175 [M+-CH3-2CO, 26.7], 160 [M+-2CH3-2CO, 
26.7], 132 [M+-2CH3-3CO, 8.8], 104 [M+-2CH3-4CO, 16.4], 76 [C6H4+, 
16.6]; 1H NMR (300 MHz, CDCl3): δ ppm 8.17 (1H, d, J~10 Hz, H-4), 
8.05 (1H, d, J= 2.1 Hz, H-2'), 7.34 (1H, d, J= 2.1 Hz, H-3'), 6.33 (d, J~10 
Hz, H-3), 4.16 (3H, s, OCH3-5), 4.05 (3H, s, OCH3-8).13C NMR (75 MHz, 
CDCl3): δ ppm 160.5 (C-2), 149.9 (C-7), 145.3 (C-2'), 144.4 (C-5), 
143.7 (C-9), 139.5 (C-4), 128.3 (C-8), 114.9 (C-6), 112.8 (C-3), 107.7 
(C-10), 105.3 (C-3'), 61.7 (OCH3-8), 60.9 (OCH3-5). 
Compound (4): White crystals; m. p. 146-147 °C; C12H8O4; Rf= 0.48 
(S2); 0.53 (S3); UV λmax (MeOH): 247, 299 nm; MS m/z (100 %): 216 
[M+, 100], 201 [M+-CH3, 4.1], 188 [M+-CO, 35.9], 173 [M+-CO-CH3, 
59.3], 158 [M+-CO-OCH3/+H, 14.4], 145 [M+-CH3-2CO, 18.9], 89 
[C7H5+, 23.7]; 1H NMR (300 MHz, CDCl3): δ ppm 7.76 (1H, d, J= 9.6, H-
4), 7.69 (1H, d, J= 2.1, H-2'), 7.34 (1H, s, H-5), 6.82 (1H, d, J= 2.1, H-
3'), 6.36 (1H, d, J=9.6, H-3), 4.29 (3H, s, OCH3-8); 13C NMR (75 MHz, 
CDCl3): δ ppm 160.4 (C-2), 147.6 (C-7), 146.6 (C-2'), 144.3 (C-4), 
143.0 (C-9), 132.8 (C-8), 126.1 (C-6), 116.4 (C-10), 114.7 (C-3), 112.9 
(C-5), 106.7 (C-3'), 61.3 (OCH3-8). 
Compound (5):Yellow crystals; m. p. 206-208 °C; C21H20O10; Rf = 0.58 
(S4), 0.19 (S5); UV spectral data: λmax nm, MeOH: 218, 266, 335, 
(+NaOMe): 222, 267, 302sh, 379; (+AlCl3): 227, 277, 300, 382, 
(+AlCl3+HCl): 234, 275, 300, 382, (+NaOAc): 227, 275, 302sh, 346, 382, 
(+NaOAc+H3BO3): 232, 275, 338; negative ESI-MS m/z: 431 [M-H]-; 1H 
NMR (300 MHz, DMSO-d6): δ ppm 7.82 (2H, d, J= 8.6 Hz, H-2'/6'), 
6.88 (2H, d, J= 8.6 Hz, H-3'/5'), 6.76 (1H, s, H-3), 6.72 (1 H, d, J= 2.1 
Hz, H-8), 6.42 (1H, d, J= 2.1 Hz, H-6), 5.12 (1H, d, J= 7.5 Hz, H-1''), 
3.85-3.20 (m, sugars protons); 13C NMR (75 MHz, DMSO-d6): δ ppm 
181.6 (C-4), 164.0 (C-2), 162.7 (C-7), 161.3 (C-5), 160.8 (C-4'), 156.6 
(C-9), 126.3 (C-2'/6'), 120.7 (C-1'), 115.9 (C-3'/5'), 105.1 (C-10), 
102.8 (C-3), 100.1 (C-1''), 99.5 (C-6), 94.8 (C-8), 77.0 (C-5''), 76.3 (C-
3''), 73.0 (C-2''), 69.4 (C-4''), 60.6 (C-6''). 
Compound (6): Yellow powder; C27H30O14; Rf = 0.32 (S4); 0.55 (S5); 
UV λmax (MeOH): 267, 332, (+NaOMe): 270, 298sh, 383, (+AlCl3): 277, 
299, 345, 383, (+AlCl3/HCl): 276, 297, 340, 383, (+NaOAc): 267, 332, 
(+NaOAc+H3BO3): 267, 332; 1H NMR (300 MHz, DMSO-d6): δ ppm 
7.93 (2H, d, J= 8.6 Hz, H-2'/6'), 6.94 (2H, d, J= 8.6 Hz, H-3'/5'), 6.85 
(1H, s, H-3), 6.79 (1H, d, J= 2.1 Hz, H-8), 6.37 (1H, d, J= 2.1 Hz, H-6), 
5.23 (1H, d,J= 7.2 Hz, H-1''), 5.13 (1H, brs, H-1'''), 3.74-3.19 (m, sugar 
protons), 1.20 (3 H, d, J= 6.0 Hz, CH3-6'''); 13C NMR (75 MHz, DMSO-
d6): δ ppm 182.0 (C-4), 164.3 (C-2), 162.6 (C-7), 161.4 (C-5), 161.1 
(C-4'), 157.4 (C-9), 128.6 (C-2'/6'), 121.0 (C-1'), 116.1 (C-3'/5'), 
105.5 (C-10), 103.2 (C-3), 100.5 (C-1'''), 99.4 (C-1''), 97.9 (C-6), 94.6 
(C-8), 77.3 (C-5''), 77.1 (C-2''), 76.4 (C-3''), 71.9 (C-4'''), 70.6 (C-2'''), 
70.5 (C-3'''), 69.7 (C-4''), 68.4 (C-5'''), 60.6 (C-6''), 18.1 (C-6'''). 
Compound (7): Faint yellow powder; m. p. 254-256 °C; C17H14O6; Rf 
= 0.91 (S4); UV spectral data: λmax nm, MeOH: 275, 332, (+NaOMe): 
272, 387; (+AlCl3): 286, 300, 360, (+AlCl3+HCl): 285, 299, 353, 
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(+NaOAc): 271, 337, (+NaOAc+H3BO3): 272, 337; ESI-MS; m/z: 314 
[M+, 93], 315 [M+H]+, 42.8], 300 [M+-CH3/+H, 19.9], 299 [M+-CH3, 
100], 271 [M+-CH3-CO, 39.3], 270 [M+-CH3/+H-CH2O, 5.4], 153 
[A1++H, 34.4], 118 [B1+, 14.9]; 1H NMR (DMSO-d6, 300 MHz): δ ppm 
7.91 (1H, d, J= 9 Hz, H-2'/6'), 6.97 (2H, d, J= 9 Hz, H-3'/5'), 6.76 (1H, 
s, H-8), 6.85 (1H, s, H-3), 3.87 (3H, s, OCH3-6), 3.73 (3H, s, OCH3-7); 
13C NMR (DMSO-d6, 75 MHz): δ ppm 182.1 (C-4), 164.0 (C-2), 161.0 
(C-4'), 158.5 (C-7), 152.5 (C-5), 152.0 (C-9), 131.8 (C-6), 128.4 (C-
2'/6'), 121.0 (C-1'), 115.2 (C-3'/5'), 105.0 (C-10), 102.5 (C-3), 91.4 
(C-8), 59.9 (OCH3-6), 56.3 (OCH3-7). 
Evaluation of antihyperlipidemic and antihyperglycemic 
activities 
Preparation of plant sample 
The fresh leaves of F. japonica (500 g) were subjected to cold 
percolation with 80 % aqueous ethanol (3×2 L) at room 
temperature. After concentration under reduced pressure, the 
ethanolic extract (60.8 g) was stored in the refrigerator until use. 
Animals 
Male Wister albino rats (250±50 g) of twenty weeks age were 
selected for this study. They were obtained from the Animal House, 
National Research Centre, Egypt. All animals were housed in a 
temperature (26-29 °C) and humidity (50-60 %) controlled 
environment in steel mesh cages of ten rats each on wood–chip 
bedding, with a fixed light/dark cycle (12 h), for one week as an 
acclimatization period with free access of water and food ad libitum. 
Anesthetic procedures and handling of animals complied with the 
ethical guidelines of the Medical Ethical Committee of National 
Research Centre in Egypt, providing that the animals did not suffer 
at any stage of the experiment. 
Experimental design 
Fifty male albino rats were selected for this study and divided into 
five groups (ten rats each) as follows: group 1: normal, healthy 
control rats, group 2: normal rats orally treated with 500 mg/kg 
body weight (BW) of an ethanolic extract of F. japonica for 45 d, 
according to LD50 which reveal the extract is safe till 1.5 g/kg BW, 
group 3: considered as diabetic groups; where diabetes was induced 
by STZ. Each rat was injected intraperitoneally with a single dose of 
STZ (60 mg/kg BW dissolved in 0.01 M citrate buffer immediately 
before use [12]. After injection, animals had free access to food and 
water and they were given 5% glucose solution to drink overnight to 
encounter hypoglycemic shock.  
Animals were checked daily for the presence of glycosuria. Animals 
were considered to be diabetic if glycosuria was present for 3 
consecutive days. After 3 d of STZ injection fasting blood samples 
were obtained and fasting blood sugar was determined (>300 
mg/dl). Hyperglycemic rats were used for the experiment and 
classified as follows: group 4: diabetic animal oral administered 500 
mg/kg BW of ethanolic extract of F. japonica for 45 d, group 5: 
diabetic rats supplemented orally with the glibenclamide (reference 
drug) at a dose of 10mg /Kg BW d for 45 d [15].  
After 45 d of treatments, rats fasted overnight (12-14 h), anesthetized 
with diethyl ether and blood collected by puncture of the sublingual vein 
in clean and dry test tube, left 10 min to clot and centrifuged at 3000 
revolutions per minute (rpm) for serum separation. The separated 
serum was used for biochemical analysis of liver function enzymes, 
blood glucose level, lipid profile and total protein content.  
Preparation of tissue homogenate  
After blood collection, rats of each group were sacrificed, the livers 
were removed immediately, weighed and homogenized in 5-10 
volumes of bidistilled water by a ratio 1:10 w/v using electrical 
homogenizer, centrifuged at 4000 rpm for 15 min, the supernatants 
were collected, and placed in eppendorf tubes, and stored at–20 °C 
and used for determination of oxidative stress markers [nitric oxide 
(NO) and malondialdehyde (MDA)], enzymatic and non-enzymatic 
antioxidant [reduced glutathione (GSH) and superoxide dismutase 
(SOD)] as well as and carbohydrate metabolizing enzymes 
[hexokinase (HK), pyruvate kinase (PK), and phosphoenolpyruvate 
carboxykinase (PEPCK)]. The homogenization was carried out as 
described by Newsholme et al. [17]. 
Liver injury biomarkers 
Glucose was determined in serum by colorimetric assay method kits 
(Biodiagnostic Chemical Company, Cairo, Egypt) according to the 
method of Trinder [18]. Alkaline phosphatase (ALP) enzyme activity 
was measured by the method of Belfield and Goldberg [19]. 
Aspartate and alanine aminotransferases (AST and ALT) enzyme 
activities were measured in serum by the method of Gella et al. [20] 
and the enzyme activity is expressed as μmol/l. Total protein 
content was assayed in serum according to the method of Bradford 
[21] and expressed as ug/l. 
Tissue biochemical analyzes 
Carbohydrates metabolizing enzymes 
Hexokinase enzyme assay in liver tissue homogenate was assayed 
according to the method described by Abrahao-Neto et al. [22]. 
Pyruvate kinase (PK) and Phosphoenolpyruvate carboxykinase 
(PEPCK) enzyme activities were determined in liver tissue 
homogenate according to the method of Bergmeyer et al. [23]. 
Oxidative stress biomarkers and enzymatic and non-enzymatic 
antioxidant  
Lipid peroxide (LPO)/malondialdehyde (MDA) [24], and nitric oxide 
(NO) [25]. Reduced glutathione (GSH) was assayed according to the 
method of Moron et al. [26] and superoxide dismutase (SOD) 
according to the method described by Paoletti et al.[27]. These 
analytical procedures were determined in the liver tissue homogenate. 
Lipid profile and kidney markers 
Total urea and creatinine were demonstrated in serum and carried 
out using diagnostic kits (Biodiagnostic Chemical Company, Cairo, 
Egypt) according to the method of Schirmeister [28] and Fawcett 
[29] respectively.  
Statistical analyses 
Data were analyzed by comparing values for different treated groups 
with the values of individual controls. Results are expressed as 
mean±SD. The significant differences among values were analyzed 
using analysis of variance (One Way Anova) coupled with Co-stat 
computer program, where unshared letters indicate significant 
difference at P ≤ 0.05. 
RESULTS 
Isolation of compounds 
Fractionation of the petroleum ether (40-60 °C) and EtOAc extracts 
of leaves of Fortunella japonica on different columns of Si gel and 
Sephadex afforded one sterol β-sitosterol (1), three coumarins 2-4, 
two glycosides 5-6 and one methoxylated flavonoid 7 (fig. 1). They 
were identified as umbelliferone (2), isopimpenellin (3), xanthotoxin 
(4), apigenin-7-O-β-D-glucopyranoside (5), apigenin-7-O-β-rhamno-
glucoside (6) and the methoxylated flavonoid; cirsimaritin (7). Their 
structures were established on the basis of detailed 
chromatographic and spectroscopic techniques (UV, MS, 1D and 2D 
NMR). 
Bioactivity study 
The present results demonstrate the biochemical effects of ethanolic 
extract of F. Japonica treatment in comparison with the current 
available hypoglycemic glibenclamide reference drug against liver 
disorders induced by reactive oxygen species in a diabetic model. 
Table 1 showed liver enzyme activities, serum glucose level and total 
protein content in normal, STZ and treated groups. The insignificant 
change was observed in normal rats treated with F. japonica extract 
as compared to normal untreated rats. Data are means±SD of ten 
rats in each group. Serum glucose level is expressed in mg/dl. Liver 
function enzyme activities are expressed in μmol/l. Total protein is 
expressed in µg/l Statistical analysis is carried out using Co-stat 
computer program coupled with post-hoc (least significance 
difference LSD. Unshared letters indicate significant difference at 
P<0.05. 
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In STZ group, a significant increase was observed in serum glucose 
levels with percentage increase reached to 225.00 %, and in liver 
function, enzyme activities; AST, ALT and ALP with percentage 
increase 213.91, 157.29 and 228.00 %, respectively. Significant 
decreases were observed in total protein content amounting to 
44.00 %, as compared to the normal control. Significant 
normalization was noticed in serum glucose level, liver enzymes and 
total protein content in the diabetic rats treated with ethanol extract 
of F. japonica with percentages of amelioration amounting to 190.19, 
191.10, 319.61, 165.03 and 31.59 %, respectively, with simultaneous 
results for glibenclamide-treated diabetic rats. 
Insignificant change in lipid profile, total cholesterol (TC), 
triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), low-
density lipoprotein cholesterol (LDL-c) and total lipids were 
reported in normal control treated rats with F. japonica ethanol 
extract (table 2). On the other hand, diabetic rats showed a 
significant increase in lipid profile; TC, TG, LDL-c and total lipid with 
percentage increase, amounting to 238.64, 177.91, 583.62 and 
129.95 %, respectively. A significant decrease in HDL-c was 
observed (68.34 %), as compared to normal control rats. Treatments 
with F. japonica extract significantly reversed these elevations and 
controlled the reduced HDL-c level with percentages of 
improvement 198.82, 134.14, 43.20, 434.38 and 229.95 %, 
respectively, for total cholesterol, triglycerides, HDL-c, LDL–c and 
total lipid. The antidiabetic reference glibenclamide drug declared 
more or less similar results (table 2). 
 
 
Glc= glucose; RhaGlc= 2-O-α-L-Rhamnopyranosyl-D-glucopyranose. 
Fig. 1: Chemical structures of the isolated compounds from 
Fortunella japonica: β-sitosterol (1), umbelliferone (2), 
isopimpinellin (3), xanthotoxin (4), apigenin-7-O-β-D-
glucopyranoside (5), apigenin-7-O-β-rhamnoglucoside (6), and 
cirsimaritin (7) 
 
Table 1: Effect of F. japonica total extract on serum glucose level, liver enzyme activities and total protein content in normal control and 
different therapeutic groups 
Parameters  Normal control F. japonica treated normally STZ treated STZ+F. japonica treated Glibenclamide 
Serum glucose  112.33±8.93a 110.13±9.00a 365.10±14.40b 151.45±3.30c 151.97±7.67c 
AST 2.66±0.11a  2.33±0.30a 8.35±0.78b 3.00±0.10a 2.85±0.35a 
ALT 1.99±0. 20a 1.32±0.10a 5.12±0.47b 2.58±0.26c  2.76±0.66c 
ALP 3.56±0.19a 3.31±0.08a 10.99±1.19b 5.19±0.14c  4.63±0. 98a 
Total protein 117.65±12.01a 118.60±7.22a 65.88±7.49b 103.10±7.11a  109.00±2.64a 
Data are means ±SD of ten rats in each group. Blood glucose level is expressed in g/dl, liver enzymes activities (AST, ALT, ALP) are expressed in   U/l  
and total protein content in ug/l. Statistical analysis is carried out using one-way analysis of variance (ANOVA) using Co-stat Computer Program. 
Unshared letters indicate significant difference at P<0.05. 
 
Table 2: Effect of F. japonica total extract on lipid profile in normal control and different therapeutic groups 
 Parameters  Normal control F. japonica treated normally STZ treated STZ+F. japonica treated Glibenclamide 
 TC 48.45±9.90a 49.10±5.35a 164.07±13.10b 67.74±8.23c 80.69±8.24d 
TG 23.99±4.16a 23.29±2.12a 66.67±9.00b 34.49±1.90c 38.18±1.57c 
HDL-c 31.11±4.09a 30.37±4.60a 9.85±1.07b 23.29±1.90c 26.82±1.62c 
LDL-c  13.00±3.12a 12.89±1.99a 90.17±11.50b 33.70±6.60c 34.23±4.65c 
Total lipids 1130.90±57.89a 1123.50±37.89a 2600.45±98.70b 1440.45±60.44c 1420.89±67.66c 
Data are means±SD of ten rats in each group. Lipid profile parameters are expressed in ug/dl except HDL, which is expressed in mg/dl, Statistical 
analysis is carried out using Co-stat computer program coupled with post-hoc (least significance difference LSD. Unshared letters indicate 
significant difference at P<0.05. 
 
An insignificant change in all antioxidant biomarkers was 
observed post-treated of normal control rats with ethanol extract 
of F. japonica. A significant increase was noticed in NO and MDA 
post STZ injections with percentage increase amounting to 82.48 
and 579.35 % respectively. A significant reduction in GSH and SOD 
levels was recorded in diabetic rats with percentages reached to 
77.27 and 80.80 %, respectively. Post treatment of diabetic rats 
with F. japonica extract, marked amelioration in NO, MDA, GSH and 
SOD levels (62.13, 590.79, 42.35 and 43.83 %, respectively) as 
compared to a standard anti-diabetic drug which recorded 
amelioration by percentages 73.39, 557.84, 35.45 and 51.31 %, 
respectively (table 3). 
 




Normal control F. japonica treated normally STZ treated STZ+F. japonica treated Glibenclamide 
NO 44.00±4.91a 42.60±4.10a 80.29±10.00b 48.00±4.71c 49.00±9.91c 
MDA 19.90±1.66a 18.00±2.90a 135.19±9.97b 24.18±2.40c 23.52±3.60c 
GSH 4.40±0.60a 4.90±0.91a 1.00±0.12b 2.56±0.34c 2.99±0.40c 
SOD 9.90±0.89a 9.00±0.90a 1.90±0.20b 6.98±1.07c 7.11±0.90c 
Data are means±SD of ten rats in each group. MDA is expressed in μ mol/g tissue. GSH and SOD are expressed in μmol/mg protein/min; NO is 
expressed in μg/g tissue. Statistical analysis is carried out using one-way analysis of variance (ANOVA) using Co-stat Computer Program. Unshared 
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An insignificant change was observed in all glycolytic and 
gluconeogenic enzyme levels as a result of treatment of normal 
control rats with ethanol extract. Significant inhibition in HK, PK, 
LDH enzyme activities (62.52, 66.61 and 58.16 %, respectively), 
while a significant increase in PEPCK (73.59 %), was observed in 
STZ-induced diabetic rats (table 4).  
 




Normal control F. japonica treated normally STZ treated STZ+F. japonica treated Glibenclamide 
HK 115.10±2.97 a  120.00±9.67a 43.12±7.60b 77.28±9.10 c 79.65±8.89d 
PK 60.50±3.40 a 60.69±3.41a 20.20±2.07b 49.40±8.00 c 50.77±6.22d 
LDH 40.37±5.10a 39.50±8.52a 16.89±2.80b 29.90±5.90c 30.10±6.40d 
PEPCK 3.90±0.34a 3.93±0.24a 1.03±0.11b 3.86±0.50a 2.99±0.43c 
Data are means±SD of ten rats in each group. PK, HK, LDH and PEPCK are expressed in μ mole/mg protein/min. Statistical analysis is carried out 
using Co-stat Computer Program coupled with post-hoc (least significance difference LSD. Unshared letters indicate significant difference at P<0.05. 
 
Marked amelioration enhancement was noticed in all the detected 
enzymes in treated diabetic groups either with the extract of F. 
japonica (37.46, 48.26, 32.23 and 72.56 %, respectively, for HK, PK, 
LDH and PEPCK), or anti-diabetic standard drug (31.47, 50.53, 32.72 
and 50.26 %, respectively), as compared to normal control. 
An insignificant change in total urea and creatinine levels in 
normally treated rats with the plant extract was observed (as 
compared to the normal control rats). The diabetic rats recorded 
significant elevation in total urea and creatinine levels (142.42 and 
324.72 %, respectively), as compared to normal control rats. 
Treatment of STZ-treated rats with plant extract restored these 
elevated levels (as compared to the normal control) with the 
percentage of improvement of 128.21 and 319.10 %, for total urea 
and creatinine respectively (table 5). Similar results were obtained 
from anti-diabetic reference drug. 
 
Table 5: Effect of F. japonica on total urea and creatinine levels in normal control and different therapeutic groups 
  Normal control F. japonica treated normal STZ treated STZ+F. japonica treated Glibenclamide 
Total urea  39.60±4.10a 37.56±2.11a 96.00±8.90b 45.23±3.56a 43.20±4.98a 
Creatinine  0.89±0.04a 0.83±0.05a 3.78±0.23 b  0.94±0.13a 0.90±0.04a 
Data are means±SD of ten rats in each group. Total urea and creatinine levels are expressed in mg/dl. Statistical analysis is carried out using one 
way analysis of variance (ANOVA) using Co-stat computer program unshared letters indicate significant difference at P<0.05. 
 
DISCUSSION 
In this study, we investigate Fortunella japonica (Thunb.) Swingle for 
its Phyto phenolics and demonstrated the ethanolic extract 
supplementation can be useful in improvement diabetic 
complications associated with hyperlipidemia and oxidative stress. 
Structural elucidation of isolated compounds 
Compound 1 was identified as β-sitosterol from its mass spectrum 
and NMR spectroscopic measurements [30]. The structures of 
compounds 2-4 were identified on the basis of interpretation of 
their physicochemical chemical analyzes (UV, MS, and NMR) and 
comparing the authentic samples or with the corresponding 
published data in the literature [31, 32]. They were identified as 
umbelliferone (2), isopimpinellin (3), and xanthotoxin (4). 
The chromatographic properties of compounds 5-7 (color under UV 
light, change with ammonia vapor, UV spectral data (using shift 
reagents), and responses towards spray reagents) can suggest their 
flavonoid characters. Complete acid hydrolysis using 2N HCl for O-
glycosides (5-6) were carried out, followed TLC using cellulose F254, 
n-butanol/pyridine/acetic acid/ethyl acetate/H2O (50:20:10:25:20) 
and aniline hydrogen phthalate as a spray reagent [14] to confirm 
the nature of sugars. This evidence supported by complete acid 
hydrolysis yielding glucose in the aqueous layer of compound 5, 
rhamnose and glucose of compound 6 while apigenin was detected 
in the organic phase.  
Two major absorption bands in the UV spectra showed at λmax 266-
275 nm (band II) and at λmax 332-335 nm (band I) for compounds 5–
7 in methanol, characteristic for the apigenin nucleus [33]. The 
position 4' of the three compounds was occupied by free one group, 
this was manifested by a bathochromic shift by+44–55 nm, in the 
presence of NaOMe of a band I and the presence of 5-OH were 
indicated by a bathochromic shift induced by AlCl3 for a band II 
without decomposition by the addition of HCl. In addition, the 
absence of 7-OH is proven by the lack of any remarked shift in the 
presence of NaOAc and the absence of a bathochromic shift in 
NaOAc/H3BO3, confirmed 7-O-substituted apigenin in compounds 5–
7. On the other hand, the absence of a bathochromic shift in both 
bands after addition of boric acid referred the absence of ortho-
dihydroxyl groups in both rings A and B in 5 and 6 [34]. 
1H NMR spectra of 5-7 showed two ortho doublets (J= 8.6-9.0 Hz) 
each integrated for two protons of an AX system at 7.82-7.93 ppm 
(H-2'/6') and 6.66-6.97 ppm (H-3'/5'), assignable to 1, 4-
disubstituted B-ring. Furthermore, the observation of H-3 as a 
singlet at 6.76-6.85 ppm were a confirmative document to a flavone 
identity for the apigenin moiety.  
Moreover, two doublets each integrated to one proton of another AX 
system of H-8 and H-6 for 5 and 6. The downfield shift of both H-6 
and H-8 (d 6.37-6.42 and d 6.72-6.79 with meta coupling (J= 2.1Hz), 
respectively) and the anomeric proton (H-1'') signal at δ 5.12-5.23 
ppm, gave evidence for the presence of ß-glycosidic moiety at 7-
position in compounds 5 and 6 [34]. The presence of a terminal α-
rhamnopyranosyl moiety in 6 was concluded from H-1''' signal 
together with doublet signal (J= 6.0 Hz) which was characteristic of 
CH3-6'''. Methoxylation at C-6 in compound 7 was indicated by the 
downfield shift of H-8 which was appeared as singlet at 6.76 ppm 
together with a singlet at 3.87 ppm for OCH3 and there is another 
singlet at 3.73 ppm for OCH3 at C-7. Inspection of the 13C NMR 
chemical shifts of 5-6 reveals slightly upfield of C-7 and the 
downfield of both C-6 and C-8, was indicative to the glycosidation at 
7-OH [33, 34]. For compound 7, the signal showed at 91.4 ppm for C-
8 pointing to the presence of a methoxy at C-7. Moreover, 
methoxylation of C-6 was concluded due to the downfield location at 
131.8 ppm. All other 13C NMR signals were completely assigned by 
comparison with previously published data of structurally related 
compounds [34].  
Accordingly, the above data, the structures of the compounds 5-7 
were identified as the flavonoid glycosides; apigenin-7-O-β-D-
glucopyranoside (5), apigenin-7-O-β-rhamnoglucoside (6) and the 
methoxylated flavonoid; cirsimaritin (7) [33, 34]. 
Compounds from 2-7 have not been shown previously to be 
constituents of F. japonica. 
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Fig. 2(a): Liver of normal control rats showed the normal 
histological structure of the hepatic lobule (H & E X 400) 
Fig. 2(b): Liver of diabetic rats showed hydropic degeneration of 
hepatocytes, sinusoidal leukocytosis and congestion of 
hepatoportal blood vessel (H & E X 400) 
  
Fig. 2 (c): Liver of diabetic rats treated with crude extract of F. 
japonica showed portal oedema (H & E X 400) 
Fig. 3 (a): Kidney of normal control rats showed the normal 
histological structure of renal parenchyma (H & E X 400) 
  
Fig. 3 (b): Kidney of diabetic rat showed atrophy of glomerular tuft and 
thickening of the parietal layer of Bowman’s capsule (H & E X 400) 
Fig. 3 (c): Kidney of diabetic rats treated with crude extract of F. 
japonica showed congestion of renal blood vessels (H & E X 400) 
  
Fig. 4(a): Pancreas of normal control rats showed no 
histopathological changes (H & E X 400) 
Fig. 4(b): Pancreas of diabetic rat showed vacuolation of epithelial 
lining pancreatic acini (H & E X 400) 
  
Fig. 4(c): Pancreas of diabetic rats treated with crude extract of F. 
japonica showed no histopathological changes (H & E X 400) 
Fig. 4(d): Pancreas of diabetic rats treated with crude extract of F. 
japonica showed no histopathological changes (H & E X 400) 
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Bioactivity study 
Phytophenolics play a crucial role in health promotion and disease 
prevention by different mechanisms related to cell differentiation, 
deactivation of pro-carcinogens, maintenance of DNA repair and 
inhibition of N-nitrosamine formation and change of estrogen 
metabolism, amongst others [35]. Major mechanisms for the 
antioxidant effect of Phyto phenolics in functional foods include free 
radical scavenging and metal chelation activities. ROS have been 
recognized to play a determining role in the pathogenesis of several 
human diseases [36]. ROS-induced oxidation can result in cell 
membrane disintegration, membrane protein damage and DNA 
mutation, which can further initiate or propagate the development 
of diseases, including diabetes [37].  
Phytophenolic compounds such as coumarins and flavonoids can 
scavenge free radicals and quench ROS and therefore provide 
effective means of preventing and treating free radical-mediated 
diseases [35, 37]. 
With diabetes, increased lipid peroxidation is associated with 
hyperlipidemia [15, 24]. Oxidative stress is, thus, produced under 
the diabetic condition and is likely involved in the progression of 
pancreatic damage [36].  
There are some examples of antihyperglycemic coumarins [12, 36]. 
The administration of coumarin-rich fraction of Ionidium 
suffruticosum along with high-fat diet significantly prevented the 
rise in the plasma total and LDL-c, triglycerides and phospholipids 
and also had showed a cardioprotective effect against 
hyperlipidemia [38]. In the current study, three coumarins 2-4 were 
isolated from F. japonica. The antihyperglycemic effect of these 
coumarins could inform their stimulatory action on intracellular 
glucose transport by causing an increase in glucose uptake by 
different cells in the absence of insulin [36]. Coumarins may also 
attenuate cytokine-induced toxicity which reduces the oxidative 
damage of the pancreas, and may ameliorate the endocrine function 
of this gland [12, 36]. An umbelliferone derivative showed to possess 
an antioxidant and antihyperlipidemic effect on the STZ-induced 
diabetic rat [11]. The effect of compound 2 (umbelliferone), isolated 
in the current study, may be due to the increased level of pancreatic 
insulin secretion and effect on the antioxidant marker [11].  
There is a direct correlation between the antioxidant property of 
medicinal plants, and their antidiabetic activity was found [39]. Also, 
a positive linear correlation was found between the antioxidant 
activity and the total phytophenolic content in plants [40], 
suggesting that phytophenolic compounds contribute significantly to 
the antioxidant capacity of the investigated plant species. Certain 
bioactive flavonoids and coumarins constituents are frequently 
implicated as having an antioxidative effect [15, 16]. 
Flavonoids are a class of important bioactive natural products and 
are being extensively used in functional foods. The flavonoids 
present in F. japonica probably also functions in reducing glucose 
levels in diabetic animals, as suggested in the case of Artemisia 
judaica, which known to be a rich of flavonoids [12]. Teucrium 
polium L. ssp. Capitatum extract contains apigenin, O-methylated 
flavone, cirsimaritin, with insulinotropic and antihyperglycemic 
effects [41]. Kim et al. [42] suggested that flavonoids may indirectly 
enhance the phosphorylation of 3-hydroxy-3-methylglutaryl CoA 
(HMG-CoA) reductase and thus diminish endogenous cholesterol 
production. HMG-CoA reductase is the rate-limiting enzyme of 
cholesterol biosynthesis.  
In the present study, apigenin derivatives (5-6) and the 
methoxylated flavonoid cirsimaritin (7) were isolated from F. 
japonica. Apigenin and its derivatives also have antihyperlipidemic 
properties and have been reported to have a role in the inhibit 
cholesterol production in the hepatocyte [42]. 
Methoxylated flavones are known to have potent hypolipidemic 
properties [43], and they were reported to reduce lipid levels in vivo 
and reduce the number of absorptive cells, villus length and hepatic 
steatosis in hyperlipidemic rats. In a previous study, Talapatra et al. 
[3] reported the presence of methoxylated flavones in F. japonica 
fruit. Cirsimaritin (compound 7) was isolated from the current plant 
is considered one of the methoxylated flavones. 
Excessive storage of fat, in the liver and the diabetic state, affects 
liver functions and increases the susceptibility to free radical attack. 
Treatment with the ethanolic extract, containing the flavone 
glycosides 5-6 and the methoxylated flavones 7, may prevent 
oxidative damage by detoxifying reactive oxygen species, thus 
reducing hyperlipidemia [44], with a concomitant decrease in ALT, 
AST, and ALP enzyme activities. The decreased ALT and AST enzyme 
activities in serum, as a result of the treatment with ethanolic 
extract, might be ascribed to the ability of phenolic compounds to 
maintain membrane integrity and thereby restrict the leakage of 
these enzymes [12, 13]. The hypolipidemic and hypoglycemic 
activities of the flavones 5-7 are likely due to their radical 
scavenging, antioxidant, and antihepatotoxic properties [15, 24]. The 
mechanism of action of phytophenolics in models of diabetes 
suggested that flavonoids are able to reduce glucose uptake and 
inhibit intestinal and renal Na+glucose co-transporter.  
Hyperglycemia exhibits the oxidative stress through several 
mechanisms [12, 36]. Lipid peroxidation is a key marker of oxidative 
stress results in extensive membrane damage and dysfunction. It 
was found that, many biochemical pathways strictly associated with 
hyperglycemia (glucose autoxidation, polyol pathway, protein 
glycation), are initiated and augmented under oxidative stress. 
Furthermore, exposure of endothelial cells to high glucose (as 
indicated in the present results), leads to the augmented production 
of superoxide anions, which may quench nitric oxide, a potent 
endothelium-derived vasodilator that participates in the general 
homeostasis of the vasculature[13,14]. The significant elevation of 
serum AST, ALT and ALP enzyme activities causes a reduction in 
total protein content as compared to the corresponding values in the 
normal control rats. These enzymes activities and total protein 
content determine the functionality and cellular integrity of the liver 
[45]. The elevated enzyme activities in serum of diabetic control rats 
reflect the alterations in the serum membrane integrity and/or 
permeability. Inconsistent with the present results, Kim et al. [42] 
found that; the activities of ALT and AST tend to increase in the 
diabetic state, resulting in an increased enzyme leakage from 
hepatocytes. Diabetes condition stimulates excessive storage of fat in 
the liver effects on liver functions and increased the susceptibility to 
free radical attack resulting in liver damage. The increases in the 
serum activities of these enzymes were found to be directly 
proportional to the degree of cellular damage [15]. In addition to, 
abnormal glucose metabolism, diabetes often involves abnormal 
lipid metabolism, which is considered as an additional metabolic 
disorder. Diabetes is initiating dramatic surge in the lipid profile of 
serum total cholesterol, total lipids and LDL-c, while circulating 
serum HDL-c level (the good cholesterol) was significantly 
diminished in the diabetic rats as compared to the normal control 
group, thus providing a model for diabetic complication [12, 14]. The 
high level of LDL-c found in diabetic rats may be attributed to a 
down-regulation in LDL receptors by cholesterol and saturated fatty 
acids included in the diet [13]. 
The current data show also that, STZ caused a reduction in GSH and 
SOD levels in the liver of diabetic rats. The decline in the activity of 
free radical scavenging enzyme SOD may be due to its inactivation 
caused by excess ROS production [46]. Assessment of blood glucose, 
and GSH were used as markers of hyperglycemia and oxidative 
stress, respectively. The depletion of GSH and antioxidant enzymes 
are associated with an increase in nitric oxide and lipid peroxidation, 
the reduction in GSH level may be a consequence of enhanced 
utilization of flavonoid compounds by the antioxidant enzymes, 
glutathione peroxidase and glutathione-S-transferase [24]. 
As compared to the control group, the diabetic group recorded a 
significant decrease in glutathione level and SOD enzyme activity, 
while MDA and NO showed dramatic elevation. Since, diabetic 
condition elicited oxidative stress resulted in elevation in hepatic 
MDA and NO, while a decline in hepatic GSH level; the non-
enzymatic antioxidant and enzymatic antioxidant activity; SOD 
defense system.  
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In our evaluation of F. japonica, the serum lipid profile (TC, TG, LDL, 
and HDL) used as markers of dyslipidemia was in accordance with 
the previous experiments [15, 47]. These experiments had been 
shown LDL-c can significantly inhibit the production of NO from 
vascular endothelial cells, whereas HDL-c enhance endothelial NO 
release. In the current study, diabetic state significantly increased 
the hepatic NO level in diabetic rats.  
Oral administration of ethanol extract of F. japonica could reverse 
the above mentioned diabetic effects. This may be through 
potentiating the pancreatic secretion of insulin from islet β-cell or 
due to elicit the transport of blood glucose to the peripheral tissue. 
In addition, Fortunella plant might increase the levels of insulin and 
C-peptide in diabetic [48]. 
One of the possible actions of the current extract may be due to its 
inhibition of endogenous synthesis of lipids [14, 15]. Furthermore, 
Fortunella plant was found to have therapeutic potential due to its 
antioxidant activity in several areas, including the capacity of 
preventing and decreasing the damages caused by hyperlipidemia 
and hyperglycaemia. 
The enhanced glycolytic enzyme activities (LDH, PK and HK), and 
suppression in gluconeogenic enzyme PEPCK in plant extract treated 
rats (table 4) suggested a greater uptake of glucose from the blood 
by liver cells [22, 49]. The activities of enzymes found that enhanced 
lipid metabolism during diabetes is shifted towards carbohydrate 
metabolism and it enhances the utilization of glucose at peripheral 
sites. A significant decrease in glycolytic enzymes and a significant 
increase in a gluconeogenic enzyme in the diabetic group were 
recorded as compared to normal control.  
Sherlock and Dooley [49], declared that that in the diabetic state, 
degradation of liver glycogen and gluconeogenesis are increased and 
glycolysis is decreased while glucose utilization is inhibited. Glucose-
6-phosphatase increases in the liver, facilitating glucose release into 
the blood. The opposing enzyme which phosphorlyates glucose, i. e 
hexokinase is unaffected by insulin and decreases in diabetes. As a 
result, the liver continues to produce glucose even with severe 
hyperglycemia. Under this circumstance the normal liver would shut 
off and deposit glycogen. As the liver plays a central and crucial role 
in the regulation of carbohydrate metabolism, its normal function is 
essential for the maintenance of blood glucose levels and a 
continued supply of organs that require a glucose energy source. 
This central role of the liver in glucose homeostasis offers a clue to 
the pathogenesis of glucose intolerance in liver diseases which is 
attributed mainly to an impaired insulin action [15, 22]. 
The effects of diabetes on renal function were assessed through 
measuring serum total urea and creatinine; a diabetic condition 
caused significantly increase in levels of serum total urea and 
creatinine as compared to the normal rats. It was found that, during 
renal dysfunction or renal damage, the concentration of the 
metabolites increased in the blood that may be due to high activities 
of xanthine oxidase, lipid peroxidation, and increased triacylglycerol 
and cholesterol levels [12, 14]. This may be correlated with 
enhanced protein catabolism and accelerated amino acid 
deamination for gluconeogenesis as they possible, an acceptable 
postulate to interpret the elevated levels of urea. 
The elevation in the serum total urea level in the diabetic control 
group indicated impairment in the normal kidney function of the 
animal, as the mechanism of removing it from the blood might have 
been affected. It may also be an indication of dysfunction at the 
glomerular and tubular levels of the kidney.  
It is well known that, many biochemical and histopathological findings 
confirmed renal damage in diabetic condition [50]. Creatinine, 
synthesized in the liver, passes into the circulation where it is taken up 
almost entirely by the skeletal muscles. Its retention in the blood is an 
evidence of kidney impairment and glomerular injury [51]. 
The data showed that administration of F. japonica significantly 
lowered the serum glucose, triglyceride and nitric oxide levels in 
diabetic rats. Moreover, F. japonica treatment increased serum 
superoxide dismutase activity and glutathione level markedly. These 
results show that the ethanolic extract F. japonica has hypoglycemic, 
hypotriglyceridemic and antioxidant effects in streptozotocin-
induced diabetic rats, suggesting that the extract supplementation 
can be useful in ameliorating diabetic complications associated with 
hyperlipidemia and oxidative stress. Also, according to the results F. 
japonica possesses valuable effects on liver and renal functions in 
diabetic rats. In addition, the leaves extract of F. japonica may find 
clinical application in the amelioration of diabetes-induced lipid 
disorders. 
The biochemical parameters were documented with histopathological 
finding which reveal hydropic degeneration of hepatocytes, sinusoidal 
leukocytosis and congestion of hepatoportal blood vessel in diabetic 
rats (photo 2b). While the kidney of diabetic rat showed atrophy of 
glomerular tuft and thickening of the parietal layer of Bowman’s 
capsule (photos 3b and 3c). Also, Pancreas of diabetic rat exhibited 
vacuolation of epithelial lining pancreatic acini (photo 4d). Treatment 
of diabetic rats with ethanol extracts of F. japonica demonstrated 
normal histological structure in kidney and pancreas architectures 
(photo 3c, 4c and 4c), while portal oedema was reported in liver 
(photo 2 c).  
Thus, it could be concluded that, F. japonica ethanol extract declared 
therapeutic potential against hepatic disorders that need further 
extensive work in order to perform as nutraceutical for 
hepatoprotective agents.  
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